Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Indian J Ophthalmol ; 1997 Sep; 45(3): 177-80
Article in English | IMSEAR | ID: sea-70483

ABSTRACT

The efficacy of topical ketorolac 0.5% in treatment of vernal keratoconjunctivitis (VKC) was evaluated in a randomised double-blind prospective trial in 21 patients. Ketorolac treated eyes showed 50.7% reduction in main symptoms of itching compared to 33.3% relief in placebo treated eyes after 2 weeks of treatment (p < 0.01). Photophobia, ropy discharge, and conjunctival injection also lessened by 39.9%, 31.6%, and 39.1%, respectively, in ketorolac treated eyes compared to 23.8%, 17.3%, and 20.3% in placebo group. Transient stinging sensation was observed in 3 (14.3%) patients on ketorolac therapy. This study shows efficacy of ketorolac 0.5% solution in controlling symptoms in VKC.


Subject(s)
Administration, Topical , Adolescent , Adult , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Child , Child, Preschool , Conjunctivitis, Allergic/drug therapy , Double-Blind Method , Female , Humans , Ketorolac , Male , Ophthalmic Solutions , Prospective Studies , Safety , Tolmetin/administration & dosage , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL